NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
19/08/2025
Voltar para busca
Dado oficial do USPTO
GLYC OBI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
27
Atualização mais recente
19/08/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 42, 44
Data de depósito
29/11/2023
Data de registro
19/08/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/08/2025
Última transação
19/08/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
3
Tipo de titular
03
Localização do titular
Taipei City, TW
Examinador
OSBORNE, AUDRIANA R
Unidade examinadora
L60
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the black stylized wording "Glyc" and the teal stylized wording "OBI" with a teal curved line below "OBI".
Titulares e representantes
Titulares
OBI PHARMA, INC.
Representantes
Ran He
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Carbide; Cellulose; Glycogen; Glycoprotein; Sulfides; Active chemical ingredients for use in the manufacture of anti-cancer drugs; Adjuvantsother than for medical or veterinary purposes; Antioxidants for use in the manufacture of pharmaceuticals; Biochemical catalysts; Biological preparations for use in industry and science; Carbonic hydrates; Chemical additives for use in the manufacture of pharmaceuticals; Chemical preparations for scientific purposesother than for medical or veterinary use; Chemical substances for analyses in laboratoriesother than for medical or veterinary purposes; Fatty acids for use in pharmaceutical; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparationsplasticscosmeticspersonal care productscoatingsadhesiveslubricants; Protein in raw material form for scientific and medical research; Proteins for use in manufacture; Proteins for use in the manufacture of drugs
Classe 5
Immunostimulants; Vaccines; Adjuvants for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposesfor cancer to be prevented or treated; Chemical reagents for medical or veterinary purposes; Enzyme preparations for medical purposes; Enzymes for medical purposes; Ferments for pharmaceutical purposes; Hormones for medical purposes; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer; Preparations of microorganisms for medical purposes; Tumor suppressing agents
Classe 42
Biological research; Biological research and analysis; Chemical analysis; Chemical research; Chemical research and analysis; Chemical research services; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research; Medical research in the field of oncology; Medical research services; Medical research services in the field of cancer; Pharmaceutical research and development; Providing information about medical research in the field of canceroncology; Providing laboratory research services in the field of gene expressioncancer biology; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific laboratory services; Scientific research; Scientific research and development; Scientific research in the field of genetics; Technical research in the field of pharmaceutical studies
Classe 44
Administering vaccines to patients; Alternative medicine services; Cancer screening services; Cultured cell bank services for medical transplantation; Health care; Health care services for treating cancer; Health assessment services; Health counselling; Human tissue bank services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical assistance; Medical screening; Medical treatment using cultured cells; Nursingmedical; Occupational therapy; Providing health information in the field of cancer prevention and treatment; Providing information in the field of cancer preventionscreeningdiagnosis and treatment; Regenerative medicine services; Remote monitoring of medical data for medical diagnosis and treatment; Telemedicine services
Publicações
Histórico de despachos e eventos da marca no USPTO.
27 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
19/08/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/07/2025
PUBO
PUBLISHED FOR OPPOSITION
01/07/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/06/2025
OTHE
CASE RETURNED TO EXAMINATION
14/02/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
14/02/2025
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
14/02/2025
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
14/02/2025
APET
ASSIGNED TO PETITION STAFF
13/02/2025
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
03/01/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/10/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/08/2024
PUBO
PUBLISHED FOR OPPOSITION
06/08/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/06/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
27/06/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
27/06/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
27/06/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
27/06/2024
DOCK
ASSIGNED TO EXAMINER
26/06/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/03/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
26/03/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
26/03/2024
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
24/01/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/01/2024
NWAP
NEW APPLICATION ENTERED
04/12/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GLYC OBI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.